Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Milmed Unico AB holds a company patent portfolio in the Biotechnology & Pharmaceuticals technology area. There is 1 pending office action currently assigned to 1 distinct examiner. STEPHENS, AMELIA CAROLE is the busiest examiner, handling 1 pending office action. The prosecution is active in 1 distinct art unit, matching the single pending action and examiner.
This concentration reflects a specific technical focus within the biotechnology sector. With 1 pending office action in total, the portfolio's current prosecution effort is centralized under one examiner. This structure allows for a direct relationship with the assigned examiner for the pending matter. Practitioners can observe that the prosecution is currently limited to 1 point of contact at the office, ensuring that all current patent office interactions for the company are filtered through 1 distinct examiner within 1 distinct art unit.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| STEPHENS, AMELIA CAROLE | 1 | 85.7% | +33.3% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18573574 | YEAST FOR THE TREATMENT OF INFLAMMATION | STEPHENS, AMELIA CAROLE | 24d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18573574 | YEAST FOR THE TREATMENT OF INFLAMMATION | STEPHENS, AMELIA CAROLE | 24d overdue |
| Art Unit | Apps |
|---|---|
| 1645 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18573574 | YEAST FOR THE TREATMENT OF INFLAMMATION | STEPHENS, AMELIA CAROLE | 1645 | §103§112DP | Final Rejection | 24d overdue | Pending | Dec 22, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial